Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder

被引:12
|
作者
Beheydt, Lieve Lia [1 ,2 ]
Schrijvers, Didier [1 ,2 ]
Docx, Lise [1 ,3 ]
Bouckaert, Filip [4 ]
Hulstijn, Wouter [1 ]
Sabbe, Bernard [1 ,2 ]
机构
[1] Univ Antwerp, CAPRI, B-2610 Antwerp, Belgium
[2] Hosp Psychiat, Univ Psychiat Ctr, Duffel, Belgium
[3] Hosp Psychiat, Broeders Alexianen, Boechout, Belgium
[4] Univ Psychiat Ctr KU Leuven, Kortenberg, Belgium
关键词
Major depression; Elderly; Psychomotor retardation; Cognitive; Escitalopram; Functional burden; EXECUTIVE DYSFUNCTION; DOUBLE-BLIND; SYMPTOMS; RETARDATION; PERFORMANCE; OLD;
D O I
10.1016/j.jad.2015.08.041
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although psychomotor retardation (PR) and cognitive disfunctioning are essential symptoms of elderly depressed patients, the differential effect of treatment with an SSRI in the elderly on these symptoms has hardly got any attention in studies with objective experimental measures. Since effects appear relatively slower in elderly, this study evaluates the effect on cognitive and psychomotor functioning as compared to mood, on four points during a twelve week follow up of monotreatment with escitalopram. Method: 28 non-demented elderly unipolar depressive patients on 5-20 mg escitalopram were compared to 20 matched healthy elderly. All participants underwent a test battery containing clinical depression measures, cognitive measures of processing speed, executive function and memory, clinical ratings of PR, and objective computerized fine motor skill-tests at the start and after 2,6 and 12 weeks. Statistical analysis consisted of a General Linear Model (GLM) repeated measures multivariate analysis of variance of completers to compare the psychomotor and cognitive outcomes of the two groups. Results: Although, apart from the significant mood effect, no interaction effects were found for the psychomotor and cognitive tasks, the means in general show a trend of differential effects in cognitive and psychomotor functions, with smaller effects and delayed timeframes and with presence of subgroups compared to mood effects. Limitation: Longer follow up studies are necessary to evaluate differential long term effects. Conclusion: In elderly, moderate effects of SSRI treatment on mood precede slow or limited effects on cognition and psychomotor retardation. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [21] Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting
    Dolberg, Ornah
    Lonn, Sara Larsson
    Kvist, Kajsa
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1301 - 1307
  • [22] Venlafaxine XR versus escitalopram treatment of major depressive disorder
    Zarra, J
    Schmidt, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S394 - S395
  • [23] Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder
    Soares, Claudio N.
    Thase, Michael E.
    Clayton, Anita
    Guico-Pabia, Christine J.
    Focht, Kristen
    Jiang, Qin
    Kornstein, Susan G.
    Ninan, Phil
    Kane, Cecelia P.
    Cohen, Lee S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (04): : 700 - 711
  • [24] Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder
    Herrera-Guzman, Ixchel
    Gudayol-Ferre, Esteve
    Lira-Mandujano, Jennifer
    Herrera-Abarca, Jorge
    Herrera-Guzman, Daniel
    Montoya-Perez, Karina
    Guardia-Olmos, Joan
    PSYCHIATRY RESEARCH, 2008, 160 (01) : 72 - 82
  • [25] Escitalopram versus venlafaxine XR in the treatment of major depressive disorder
    Montgomery, S.
    Andersen, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S233
  • [26] Escitalopram in the treatment of major depressive disorder: A meta-analysis
    Kennedy, Sidney H.
    Andersen, Henning F.
    Thase, Michael E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 161 - 175
  • [27] Escitalopram vs venlafaxine XR treatment of major depressive disorder
    Montgomery, SA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S207 - S207
  • [28] Escitalopram in the Treatment of Major Depressive Disorder in Adolescent Patients1 Profile Report
    Yang, Lily P. H.
    Scott, Lesley J.
    CNS DRUGS, 2010, 24 (07) : 621 - 623
  • [29] The efficacy of citalopram or escitalopram in patients with asthma and major depressive disorder
    Agarwal, Catherine D.
    Palka, Jayme M.
    Gajewski, Alexander J.
    Khan, David A.
    Brown, Sherwood
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 374 - 382
  • [30] Escitalopram prevents relapse in older patients with major depressive disorder
    Gorwood, Philip
    Weiller, Emmanuelle
    Lemming, Ole
    Katona, Cornelius
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (07): : 581 - 593